Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - ARENA PHARMACEUTICALS INC | d253408d8k.htm |
| EX-10.1 - COMMON STOCK PURCHASE AGREEMENT - ARENA PHARMACEUTICALS INC | d253408dex101.htm |
Exhibit 12.1
Statement Regarding Computation of Ratios
(In thousands)
| Year Ended December 31, | Six
Months Ended June 30, 2011 |
|||||||||||||||||||||||
| 2006 | 2007 | 2008 | 2009 | 2010 | ||||||||||||||||||||
| Earnings: |
||||||||||||||||||||||||
| Consolidated loss before income taxes |
$ | (86,248 | ) | $ | (143,166 | ) | $ | (237,293 | ) | $ | (153,899 | ) | $ | (124,534 | ) | $ | (62,806 | ) | ||||||
| Add: Fixed Charges |
2,337 | 3,959 | 6,686 | 19,018 | 21,899 | 7,953 | ||||||||||||||||||
| Amortization of capitalized interest |
— | — | 6 | 43 | 43 | 21 | ||||||||||||||||||
| Less: Capitalized interest |
— | — | (860 | ) | — | — | — | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Earnings as defined |
$ | (83,911 | ) | $ | (139,207 | ) | $ | (231,461 | ) | $ | (134,838 | ) | $ | (102,592 | ) | $ | (54,832 | ) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Fixed charges: |
||||||||||||||||||||||||
| Interest expense |
$ | 1,838 | $ | 3,520 | $ | 6,313 | $ | 18,718 | $ | 21,681 | $ | 7,876 | ||||||||||||
| Estimated interest component of rent expense |
499 | 439 | 373 | 300 | 218 | 77 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total fixed charges |
$ | 2,337 | $ | 3,959 | $ | 6,686 | $ | 19,018 | $ | 21,899 | $ | 7,953 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Ratio of earnings to fixed charges (1) |
— | — | — | — | — | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Deficiency of earnings available to cover fixed charges |
$ | (86,248 | ) | $ | (143,166 | ) | $ | (238,147 | ) | $ | (153,856 | ) | $ | (124,491 | ) | $ | (62,785 | ) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Combined fixed charges and preferred stock dividends: |
||||||||||||||||||||||||
| Fixed charges |
$ | 2,337 | $ | 3,959 | $ | 6,686 | $ | 19,018 | $ | 21,899 | $ | 7,953 | ||||||||||||
| Preferred stock dividend requirements of the registrant |
2,031 | 2,114 | 1,912 | — | — | 2,260 | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Total combined fixed charges and preferred stock dividends |
$ | 4,368 | $ | 6,073 | $ | 8,598 | $ | 19,018 | $ | 21,899 | $ | 10,213 | ||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Ratio of earnings to combined fixed charges and preferred stock dividends (1) |
— | — | — | — | — | — | ||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Deficiency of earnings available to cover combined fixed charges and preferred stock dividends |
$ | (88,279 | ) | $ | (145,280 | ) | $ | (240,059 | ) | $ | (153,856 | ) | $ | (124,491 | ) | $ | (65,045 | ) | ||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| (1) | Earnings were insufficient to cover total fixed charges and total combined fixed charges and preferred stock dividends. |